{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:29:34Z","timestamp":1794050974219,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7643","license":[{"start":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:00:00Z","timestamp":1487721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/nature21405","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T10:42:33Z","timestamp":1487673753000},"page":"113-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1829,"title":["Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection"],"prefix":"10.1038","volume":"543","author":[{"given":"Justin","family":"Eyquem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mansilla-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Giavridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoukje J. C.","family":"van der Stegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Hamieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Cunanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlesha","family":"Odak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Sadelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"key":"BFnature21405_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2015.01.002","volume":"33","author":"MC Jensen","year":"2015","unstructured":"Jensen, M. C. & Riddell, S. R. Designing chimeric antigen receptors to effectively and safely target tumors. Curr. Opin. Immunol . 33, 9\u201315 (2015)","journal-title":"Curr. Opin. Immunol"},{"key":"BFnature21405_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm827","volume":"9","author":"RJ Brentjens","year":"2003","unstructured":"Brentjens, R. J. et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat. Med . 9, 279\u2013286 (2003)","journal-title":"Nat. Med"},{"key":"BFnature21405_CR3","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1172\/JCI80010","volume":"125","author":"M Sadelain","year":"2015","unstructured":"Sadelain, M. CAR therapy: the CD19 paradigm. J. Clin. Invest . 125, 3392\u20133400 (2015)","journal-title":"J. Clin. Invest"},{"key":"BFnature21405_CR4","unstructured":"Sadelain, M. & Mulligan, R. C. Efficient retroviral-mediated gene transfer into murine primary lymphocytes. Ninth International Immunology Congress, Budapest. 88:34. (1992)"},{"key":"BFnature21405_CR5","doi-asserted-by":"publisher","first-page":"16015","DOI":"10.1038\/mto.2016.15","volume":"3","author":"X Wang","year":"2016","unstructured":"Wang, X. & Rivi\u00e8re, I. Clinical manufacturing of CAR T cells: foundation of a promising therapy. Mol. Ther. Oncolytics . 3, 16015 (2016)","journal-title":"Mol. Ther. Oncolytics"},{"key":"BFnature21405_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1089\/hum.2005.16.1241","volume":"16","author":"J Ellis","year":"2005","unstructured":"Ellis, J. Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum. Gene Ther . 16, 1241\u20131246 (2005)","journal-title":"Hum. Gene Ther"},{"key":"BFnature21405_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1182\/blood-2011-09-349993","volume":"119","author":"I Rivi\u00e8re","year":"2012","unstructured":"Rivi\u00e8re, I., Dunbar, C. E. & Sadelain, M. Hematopoietic stem cell engineering at a crossroads. Blood 119, 1107\u20131116 (2012)","journal-title":"Blood"},{"key":"BFnature21405_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/hum.2014.2525","volume":"25","author":"C von Kalle","year":"2014","unstructured":"von Kalle, C., Deichmann, A. & Schmidt, M. Vector integration and tumorigenesis. Hum. Gene Ther . 25, 475\u2013481 (2014)","journal-title":"Hum. Gene Ther"},{"key":"BFnature21405_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cell.2015.12.035","volume":"164","author":"AV Wright","year":"2016","unstructured":"Wright, A. V., Nu\u00f1ez, J. K. & Doudna, J. A. Biology and applications of CRISPR systems: harnessing nature\u2019s toolbox for genome engineering. Cell 164, 29\u201344 (2016)","journal-title":"Cell"},{"key":"BFnature21405_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrg.2016.28","volume":"17","author":"SQ Tsai","year":"2016","unstructured":"Tsai, S. Q. & Joung, J. K. Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat. Rev. Genet . 17, 300\u2013312 (2016)","journal-title":"Nat. Rev. Genet"},{"key":"BFnature21405_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nmeth.1674","volume":"8","author":"A Lombardo","year":"2011","unstructured":"Lombardo, A. et al. Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat. Methods 8, 861\u2013869 (2011)","journal-title":"Nat. Methods"},{"key":"BFnature21405_CR12","doi-asserted-by":"publisher","first-page":"307ra156","DOI":"10.1126\/scitranslmed.aac5530","volume":"7","author":"BD Sather","year":"2015","unstructured":"Sather, B. D. et al. Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template. Sci. Transl. Med. 7, 307ra156 (2015)","journal-title":"Sci. Transl. Med."},{"key":"BFnature21405_CR13","doi-asserted-by":"publisher","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","volume":"5","author":"RJ Brentjens","year":"2013","unstructured":"Brentjens, R. J. et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci. Transl. Med. 5, 177ra38 (2013)","journal-title":"Sci. Transl. Med."},{"key":"BFnature21405_CR14","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1093\/nar\/gkv1121","volume":"44","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery. Nucleic Acids Res . 44, e30 (2016)","journal-title":"Nucleic Acids Res"},{"key":"BFnature21405_CR15","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1182\/blood-2015-11-683235","volume":"127","author":"N Hubbard","year":"2016","unstructured":"Hubbard, N. et al. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome. Blood 127, 2513\u20132522 (2016)","journal-title":"Blood"},{"key":"BFnature21405_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1006\/jaut.2001.0504","volume":"16","author":"A Corthay","year":"2001","unstructured":"Corthay, A., Nandakumar, K. S. & Holmdahl, R. Evaluation of the percentage of peripheral T cells with two different T cell receptor alpha-chains and of their potential role in autoimmunity. J. Autoimmun . 16, 423\u2013429 (2001)","journal-title":"J. Autoimmun"},{"key":"BFnature21405_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/nbt.2959","volume":"32","author":"PJ de Vree","year":"2014","unstructured":"de Vree, P. J. et al. Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping. Nat. Biotechnol . 32, 1019\u20131025 (2014)","journal-title":"Nat. Biotechnol"},{"key":"BFnature21405_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","volume":"28","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z. et al. Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells. Cancer Cell 28, 415\u2013428 (2015)","journal-title":"Cancer Cell"},{"key":"BFnature21405_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn, S. D. et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol . 10, 29\u201337 (2009)","journal-title":"Nat. Immunol"},{"key":"BFnature21405_CR20","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni, L. et al. A human memory T cell subset with stem cell-like properties. Nat. Med . 17, 1290\u20131297 (2011)","journal-title":"Nat. Med"},{"key":"BFnature21405_CR21","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/sj.gt.3300506","volume":"4","author":"HF Gallardo","year":"1997","unstructured":"Gallardo, H. F., Tan, C. & Sadelain, M. The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes. Gene Ther . 4, 1115\u20131119 (1997)","journal-title":"Gene Ther"},{"key":"BFnature21405_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long, A. H. et al. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat. Med . 21, 581\u2013590 (2015)","journal-title":"Nat. Med"},{"key":"BFnature21405_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/leu.2015.247","volume":"30","author":"D Sommermeyer","year":"2016","unstructured":"Sommermeyer, D. et al. Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo. Leukemia 30, 492\u2013500 (2016)","journal-title":"Leukemia"},{"key":"BFnature21405_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/2326-6066.CIR-14-0186","volume":"3","author":"MJ Frigault","year":"2015","unstructured":"Frigault, M. J. et al. Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells. Cancer Immunol. Res . 3, 356\u2013367 (2015)","journal-title":"Cancer Immunol. Res"},{"key":"BFnature21405_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1600-065X.2003.00083.x","volume":"196","author":"AG Schrum","year":"2003","unstructured":"Schrum, A. G., Turka, L. A. & Palmer, E. Surface T-cell antigen receptor expression and availability for long-term antigenic signaling. Immunol. Rev . 196, 7\u201324 (2003)","journal-title":"Immunol. Rev"},{"key":"BFnature21405_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S1074-7613(00)00066-2","volume":"13","author":"H Liu","year":"2000","unstructured":"Liu, H., Rhodes, M., Wiest, D. L. & Vignali, D. A. On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity 13, 665\u2013675 (2000)","journal-title":"Immunity"},{"key":"BFnature21405_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.immunol.23.021704.115625","volume":"23","author":"ME Call","year":"2005","unstructured":"Call, M. E. & Wucherpfennig, K. W. The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu. Rev. Immunol . 23, 101\u2013125 (2005)","journal-title":"Annu. Rev. Immunol"},{"key":"BFnature21405_CR28","doi-asserted-by":"publisher","first-page":"e10134","DOI":"10.7554\/eLife.10134","volume":"5","author":"KA Allison","year":"2016","unstructured":"Allison, K. A. et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. eLife 5, e10134 (2016)","journal-title":"eLife"},{"key":"BFnature21405_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","volume":"35","author":"A Schietinger","year":"2014","unstructured":"Schietinger, A. & Greenberg, P. D. Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol . 35, 51\u201360 (2014)","journal-title":"Trends Immunol"},{"key":"BFnature21405_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol . 15, 486\u2013499 (2015)","journal-title":"Nat. Rev. Immunol"},{"key":"BFnature21405_CR31","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","volume":"92","author":"I Rivi\u00e8re","year":"1995","unstructured":"Rivi\u00e8re, I., Brose, K. & Mulligan, R. C. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl Acad. Sci. USA 92, 6733\u20136737 (1995)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature21405_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nbt0102-70","volume":"20","author":"J Maher","year":"2002","unstructured":"Maher, J., Brentjens, R. J., Gunset, G., Rivi\u00e8re, I. & Sadelain, M. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR\u03b6\/CD28 receptor. Nat. Biotechnol . 20, 70\u201375 (2002)","journal-title":"Nat. Biotechnol"},{"key":"BFnature21405_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.neo.7900018","volume":"1","author":"MC Gong","year":"1999","unstructured":"Gong, M. C. et al. Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen. Neoplasia 1, 123\u2013127 (1999)","journal-title":"Neoplasia"},{"key":"BFnature21405_CR34","doi-asserted-by":"publisher","first-page":"9080","DOI":"10.1158\/0008-5472.CAN-05-0436","volume":"65","author":"TP Gade","year":"2005","unstructured":"Gade, T. P. et al. Targeted elimination of prostate cancer by genetically directed human T lymphocytes. Cancer Res . 65, 9080\u20139088 (2005)","journal-title":"Cancer Res"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature21405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature21405","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature21405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:59:48Z","timestamp":1684418388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature21405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,22]]},"references-count":34,"journal-issue":{"issue":"7643","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFnature21405"],"URL":"https:\/\/doi.org\/10.1038\/nature21405","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727330544.793597023","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,22]]},"assertion":[{"value":"30 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S. is a cofounder of and consultant for Juno Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}